Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study

PaperCitations, authors & open-access status

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 50 citations, 2022 year and gold oa status.

50
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Yuchen Yang
Author
Radiomics and Machine Learning in Medical Imaging
Topic
Radiomics and Machine Learning in Medical Imaging
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account